| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.42 | 0.03 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |